APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies
Clinical trial NCT03386526 · COMPLETED
Trial details
- NCT number
- NCT03386526
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2022-10-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.